Correlation Between Conduit Pharmaceuticals and Syra Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Syra Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Syra Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Conduit Pharmaceuticals and Syra Health Corp, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Syra Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Syra Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Syra Health.

Diversification Opportunities for Conduit Pharmaceuticals and Syra Health

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Conduit and Syra is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Syra Health Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syra Health Corp and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Syra Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syra Health Corp has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Syra Health go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Syra Health

Considering the 90-day investment horizon Conduit Pharmaceuticals is expected to under-perform the Syra Health. But the stock apears to be less risky and, when comparing its historical volatility, Conduit Pharmaceuticals is 1.65 times less risky than Syra Health. The stock trades about -0.24 of its potential returns per unit of risk. The Syra Health Corp is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  10.00  in Syra Health Corp on October 9, 2025 and sell it today you would lose (1.00) from holding Syra Health Corp or give up 10.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.08%
ValuesDaily Returns

Conduit Pharmaceuticals  vs.  Syra Health Corp

 Performance 
       Timeline  
Conduit Pharmaceuticals 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Conduit Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Syra Health Corp 

Risk-Adjusted Performance

Soft

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Syra Health Corp are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating basic indicators, Syra Health sustained solid returns over the last few months and may actually be approaching a breakup point.

Conduit Pharmaceuticals and Syra Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Conduit Pharmaceuticals and Syra Health

The main advantage of trading using opposite Conduit Pharmaceuticals and Syra Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Syra Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syra Health will offset losses from the drop in Syra Health's long position.
The idea behind Conduit Pharmaceuticals and Syra Health Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Global Correlations
Find global opportunities by holding instruments from different markets